The Himalaya Drug Company's Liv 52, is the top selling drug in the country in value terms and have 35% market. The brand is valued as  Rs 107 crore brand and has registered 28.68 percent

The Himalaya Drug Company's Liv 52, has a market share of close to 35 percent and it is an Rs 107 crore brand and has registered 28.68 percent growth over the previous year. The hepato-protective market, is valued at over Rs. 300 crore and growing at 12 per cent, Liv 52 alone is growing at 28.68 per cent.

 According to ORG IMS' 2007 sales figures, for the first time, an ayurvedic drug, Liv-52, has become the top selling drug in the country in value terms. The liver tonic has registered the highest sales by value, toppling traditional chemical-based best-sellers of domestic and global pharma majors such as Pfizer's Corex, Nicholas Piramal's Phensedyl and last month's best-seller Novartis' pain-killer drug Voveran. Ayurveda-based drugs are nowhere in the top pharma sales index, and Liv-52 is the lone representation in the country's Top 30 drugs list.

Liv 52 was the only herbal pharmaceutical product in this list, attesting to the efficacy of scientifically researched herbal drugs. The product was also the uncontested leader in the hepato-protective (liver disorders) segment. Developed in the 1950s, Liv 52 continues to be top selling medicine in India and is becoming increasingly popular amongst the medical fraternity internationally registered in over 25 countries with one billion tablets and 13 million syrup bottles being sold every year across the globe.